Karim et al., 1994 - Google Patents
Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodiesKarim et al., 1994
- Document ID
- 16931613930963149672
- Author
- Karim B
- Béliard R
- Huart J
- Bourel D
- Publication year
- Publication venue
- Immunology letters
External Links
Snippet
Eight murine anti-TNF α monoclonal antibodies (mAb) were produced after immunization of BALB/c mice with rhTNF α. Six of these mAbs were able to neutralize cytotoxic activity of TNF α against L929 cells. Two other mAbs had no neutralizing effect. Epitope mapping studies …
- 108010045030 monoclonal antibodies 0 title abstract description 74
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0366043B1 (en) | Monoclonal antibody | |
| US5360716A (en) | Human tumor necrosis factor αspecific monoclonal antibody and method for detecting human tumor necrosis factor α | |
| Möller et al. | Monoclonal antibodies to human tumor necrosis factor α: in vitro and in vivo application | |
| Bringman et al. | Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes | |
| FI93025C (en) | Recombinant Lymphotoxin | |
| KR900004420B1 (en) | Antibody for interleukin-1 | |
| Liang et al. | Production and characterization of monoclonal antibodies against recombinant human tumor necrosis factor/cachectin | |
| AU679909B2 (en) | Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon | |
| US5654407A (en) | Human anti-TNF antibodies | |
| Abrams et al. | Development of rat anti-mouse interleukin 3 monoclonal antibodies which neutralize bioactivity in vitro. | |
| JP2837160B2 (en) | A therapeutic agent for sepsis and a therapeutic agent for rheumatic diseases containing a monoclonal antibody against human tumor necrosis factor | |
| EP0364778B1 (en) | Antibody against interleukin-1beta | |
| JP4750795B2 (en) | Interleukin-15 antagonist peptide | |
| CN102617735A (en) | Antibodies against human IL17 and uses thereof | |
| CN1070611C (en) | Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor | |
| Kasahara et al. | Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1 alpha (IL 1 alpha). | |
| AU641178B2 (en) | Prohormone cleavage site blocking antibody | |
| EP0462623A1 (en) | Monoclonal antibodies to human immune interferon | |
| WO1991008774A1 (en) | Cytokine antibody for the treatment of sepsis | |
| Karim et al. | Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodies | |
| Egan et al. | Characterization of monoclonal antibodies to ovine tumor necrosis factor-α and development of a sensitive immunoassay | |
| Ziltener et al. | Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivo. | |
| Ziltener et al. | Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3. | |
| JPH02227095A (en) | Monoclonal antibody | |
| JPH08506736A (en) | Monoclonal antibodies against alpha-TNF type I receptor, method for producing same and use |